Dare Bioscience
DARE
27 hedge funds and large institutions have $6.67M invested in Dare Bioscience in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 1 reducing their positions, and 1 closing their positions.
700% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 1
600% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 1
200% more capital invested
Capital invested by funds: $2.22M → $6.67M (+$4.45M)
29% more funds holding
Funds holding: 21 → 27 (+6)
0.42% more ownership
Funds ownership: 0.59% → 1.01% (+0.42%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.52M |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$169K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$143K |
| 4 |
Goldman Sachs
New York
|
+$135K |
| 5 |
Two Sigma Advisers
New York
|
+$135K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$17K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$8.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RJA
26
Raymond James & Associates
St Petersburg,
Florida
| – | -$17K | -1,433 | Closed |
|
27
Wells Fargo
San Francisco,
California
| – | +$56 | +4 | +27% |
|
DARE Hedge Fund Activity: Q4 2020 in Review
27 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q4 2020, worth a combined $6.67M — up 200% from $2.22M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new DARE positions and 1 closed out — a net gain of 6 holders — while 8 added to existing stakes and 1 trimmed.
The largest buyer was Vanguard Group, adding an estimated $2.52M. The largest seller was Raymond James & Associates, exiting entirely with an estimated $17K sold.
- 27 institutional investors held Dare Bioscience (DARE) as of Q4 2020, up from 21 in Q3 2020.
- Funds reported $6.67M of Dare Bioscience stock for Q4 2020, up 200% quarter-over-quarter.
- 7 funds opened new Dare Bioscience positions in Q4 2020 and 1 closed out, a net change of +6 holders.
- The largest Dare Bioscience buyer in Q4 2020 was Vanguard Group, an estimated $2.52M added.
- The largest Dare Bioscience seller in Q4 2020 was Raymond James & Associates, an estimated $17K sold.
Based on aggregated 13F filings for Q4 2020.